BREWIN DOLPHIN WEALTH MANAGEMENT LTD - RXI PHARMACEUTICALS CORP NEW ownership

Quarter-by-quarter ownership
BREWIN DOLPHIN WEALTH MANAGEMENT LTD ownership history of RXI PHARMACEUTICALS CORP NEW
ValueSharesWeighting
Q4 2017$6
+20.0%
100.0%0.00%
Q3 2017$5100.00%
Other shareholders
RXI PHARMACEUTICALS CORP NEW shareholders Q1 2018
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 397,371$284,0000.02%
Hudson Bay Capital Management LP 428,812$306,0000.00%
FNY Partners Fund LP 179$00.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 38$00.00%
Virtu KCG Holdings LLC 27,689$20,0000.00%
IFP Advisors, Inc 1$00.00%
Advisor Group, Inc. 163$00.00%
BANK OF AMERICA CORP /DE/ 1,096$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 26,638$19,0000.00%
DEUTSCHE BANK AG\ 1,396$00.00%
View complete list of RXI PHARMACEUTICALS CORP NEW shareholders